MedPath

The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease

Not Applicable
Conditions
Alzheimer's Disease
Interventions
Device: Deep Brain Stimulation (Beijing PINS Medical Co., Ltd)
Registration Number
NCT02253043
Lead Sponsor
Beijing Pins Medical Co., Ltd
Brief Summary

Purpose: The purpose of this clinical study is to verify the long term effectiveness and safety of a bilateral deep brain stimulation (DBS) produced by Beijing PINS Medical Co., Ltd. as a treatment option for patients with cognitive, behavioral, and functional disability of Alzheimer's disease.

Detailed Description

Other: Deep Brain Stimulation Implanted device Subjects will then be instructed to apply PINS Deep Brain Stimulation Device for 12 month.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  1. Subject is aged 40 to 80 years old;
  2. Subject with AD diagnosed according to the criteria for probable AD as defined by the National Institute of Neurological Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA);
  3. Subject have received the diagnosis of AD within the past 2 years;
  4. Subject have a CDR of 0.5 or 1.0;
  5. Score between 20 and 28 on the Mini Mental State Examination
  6. have been taking a stable dose of cholinesterase inhibitors for a minimum of 6 months.
Exclusion Criteria
  1. Patients with hearing impairment;
  2. Failures of important organs and in severe conditions
  3. Be reluctant or disabled to receive neuropsychological assessments;
  4. Participate in other clinical trial;
  5. Has a life expectancy of < 1 year.
  6. The investigator and/or enrollment review committee, would preclude participation in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Deep Brain StimulationDeep Brain Stimulation (Beijing PINS Medical Co., Ltd)DBS Implant and stimulation
Primary Outcome Measures
NameTimeMethod
Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-Cog)12 month

Change from Baseline

Secondary Outcome Measures
NameTimeMethod
Clinical Dementia Rating Scale12 month

Change from Baseline

Trial Locations

Locations (2)

301 Hospatl

🇨🇳

Beijing, Beijing, China

Beijing Tiantan Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath